TriangleHEALTH PROFESSIONAL · SOURCE READING
Brachytherapy
Source: Prostate Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: May 14, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment Option Overview for Prostate Cancer / Radiation Therapy and Radiopharmaceutical Therapy
Patients are often offered brachytherapy because of the following favorable characteristics:
Low Gleason score.
Low PSA level.
Stage T1 to T2 tumors.
More information and further study are required to better define the effects of modern interstitial brachytherapy on disease control and QOL and to determine the contribution of favorable patient selection to outcomes.[80][Level of evidence C3]
Source links and citations
Information about ongoing clinical trials is available from the NCI website.
Source links and citations
Publication references
Read the original reference and check its publication notices.
Preserved source evidence · Not medical advice